Abstract: The invention provides a process for production of carbon nanotubes whereby a laminate prepared by alternating lamination of a metal catalyst and a material other than the metal catalyst is cut to expose the laminated structure, and carbon nanotubes are grown on the metal catalyst at the cut surface of the laminate. The process results in high-quality carbon nanotubes, with minimized bundle growth, which are each individually and independently arranged in a highly precise manner at prescribed locations. The invention also provides a carbon nanotube production process comprising a step of preparing a substrate which is inclined in one or two dimensions from a specific highly symmetrical crystal orientation and vapor depositing a metal catalyst along the atomic steps appearing on the surface of the substrate, and a step of growing the carbon nanotubes by chemical vapor deposition (CVD) using the metal catalyst as nuclei.

Abstract: A partial image is cut out from an input image. A first classifier judges whether the partial image includes a face facing a direction within a first angular range. Another classifier judges whether the partial image includes a face facing a direction within another angular range that partially overlaps with the first angular range. The partial image is judged to include a face facing a direction within a specific angular range, which is the first angular range from which the portion that overlaps with the other angular range has been removed, if the first classifier judges that the image includes a face facing a direction within the first angular range, and the other classifier judges that the image does not include a face facing the second angular range. Each classifier is generated by machine learning, and judges whether images include faces facing directions corresponding to predetermined angular ranges.

Abstract: The invention concerns safe non-interacting drug combinations of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, which is (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof (the Agent) and a drug which is either an inducer, inhibitor or a substrate of cytochrome P450, in particular cytochrome P450 isoenzyme 3A4. Particular combinations are useful in treating hyperlipidaemia in humans who are receiving immunosuppressive chemotherapy. A preferred combination is the Agent and a fibrate drug, the use of such a combination in treating hyperlipidaemia in mammals, and medicaments containing such a combination for use in such treatments.

Abstract: The present invention provides, for example, a target detecting device comprising a target capturer, means for releasing the target capturer, light irradiating means and light detecting means, the target capturer at least partially containing a region interactive with an electrically conductive member, being capable of capturing a target, and being capable of emitting light upon irradiation with light in the case of not interacting with the electrically conductive member, the means for releasing the target capturer serving to release the target capturer from the electrically conductive member by ceasing the interaction between the target capturer and the electrically conductive member, the light irradiating means serving to apply light to the electrically conductive member, and the light detecting means serving to detect light emitted by the target capturer upon irradiation of light applied by the light irradiating means.

Abstract: A molecule-releasing apparatus includes a releasing unit configured to release molecules, wherein the releasing unit comprises at least one conductive member and releases molecules electrically interacting with the conductive member to which a potential is applied, from the conductive member by changing the potential so as to remove the interaction. In a moleculue-releasing method, molecules electrically attracted to two or more conductive members are released by electrical repulsion from the conductive members at different times. The molecule-releasing apparatus and molecule-releasing method are capable of efficiently releasing or transferring various useful molecules such as DNA molecules, into targets such as cells and can be safely applied for use in gene therapy and other applications.

Abstract: A semiconductor device includes a substrate; a gate electrode formed on the substrate; a gate insulating film covering the gate electrode; a carbon nanotube disposed above the gate electrode and coming in contact with the gate insulating film; and a source electrode and a drain electrode formed apart from one another in a longitudinal direction of the carbon nanotube.

Abstract: A transfer medium for use in a printing apparatus wherein a magnetic ink layer containing magnetic particles is heat-melted and transferred to a material to be printed. The magnetic ink layer contains magnetic particles different from each other in size, which enables printing to be conducted with an excellent quality.

Abstract: A transfer medium for use in a printing apparatus wherein a magnetic ink layer containing magnetic particles is heat-melted and transferred to a material to be printed. The magnetic ink layer (12) contains magnetic particles (121) and (122) different from each other in size, which enables printing to be conducted with excellent quality.

Abstract: A printer and method of printing on a transfer medium utilizing thermoplastic magnetic ink. A thermal head selectively applies thermal energy to melt selected portions of the thermoplastic magnetic ink. A magnetic head substantially spatially fixed relative to the thermal head applies the magnetic force to the thermoplastic ink which causes the melted portions to be ejected onto the transfer medium. A strip of thermoplastic magnetic ink medium is positioned to slide between the thermal head and the transfer medium. The strip includes a base layer facing the thermal head and a magnetic thermoplastic ink layer facing the transfer medium. A first movement mechanism moves either the transfer medium or the thermal and magnetic heads relative to the other at a first speed. A second movement mechanism moves the magnetic thermoplastic ink medium strip relative to the magnetic and thermal heads at a second speed. The first and second speeds are unequal.

Abstract: In an electrothermal transfer system which uses a sheet formed by integrally binding at least a resistive layer and an ink layer and effects desired transfer by flowing electric current through the resistive layer thereby causing the resistive layer to generate joulean heat and enabling the ink layer to be partially fused to be transferred, an electrothermal transfer recording sheet has the resistive layer formed by application of a mixture of carbon black with a resin binder. The carbon black used herein is possessed of a DBP oil absorption capacity of not less than 300 ml/100 g. Thus, the carbon black content in the resistive layer can be as small as 5 to 35% by weight, the tight adhesiveness of the resistive layer improved, and the power consumption lowered.

Abstract: A magnetic recording medium having good durability comprising a substrate and one or two magnetic layers at least a surface of which contains at least one compound selected from the group consisting of a compound of the formula:F--(CF.sub.2).sub.n --COO--(RO).sub.m --CO--R'--COOH (I)wherein R is a C.sub.2 -C.sub.10 alkyl group, R' is a C.sub.2 -C.sub.10 alkyl or alkenyl group, n is an integer of 4 to 20 and m is an integer of 5 to 50 and salts thereof.

Abstract: An ink composition for thermal transfer printing of about 30 to 50 weight percent of a masterbatch including a pigment or dye uniformly dispersed in a copolymer of at least one of styrene and an .alpha.-olefin and at least one of a maleic anhydride and a dialkyl maleate and about 50 to 70 weight percent wax or resin is provided. The ink composition is suitable for use as the ink layer of an electrothermal transfer recording sheet.